Urinary Congophilia as an Indicator of Activity of Lupus Nephritis
ConditionLupus Nephritis (LN)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
Evaluation of the impact of SLE on urinary levels of congophilia and their relationship to renal histopathology and activity of lupus nephritis (LN)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Any patient has evidence of nephritis that may cause proteinuria as diabetes mellitus and any other causes of glomerulonephritis other than lupus nephritis
pregnant females with lupus nephritis and hypertensive disorders
Trial population
Adult patients ≥ 18 years old that were diagnosed with SLE according to EULAR/ACR classification criteria 2019 for SLE, and lupus nephritis based on renal biopsy or active urinary sediment (proteinuria or hematuria ) ,all are included in this study
Trial design
Design model
Case-crossover
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
urinary congophilia level in patient with lupus nephritis is a marker for disease activity
Urinary congophilia levels increase in patients with lupus nephritis so that it can be used as a non-invasive urinary marker of lupus nephritis activity.
Time frame
baselineLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Assuit University ,Faculty of Medicine Status unavailable 71516, Assute, Assute
Egypt
EgyptSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: